Hikma Pharmaceuticals Plc Holding(s) in Company (2673M)
April 26 2018 - 8:40AM
UK Regulatory
TIDMHIK
RNS Number : 2673M
Hikma Pharmaceuticals Plc
26 April 2018
TR-1: Standard form for notification of major holdings
LONDON, 26 April 2018 - Hikma Pharmaceuticals PLC (LSE: HIK)
(DIFX: HIK)
(LEI: 549300BNS685UXH4JI75) announces as follows:
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant
issuer and to the FCA in Microsoft Word format if possible)(i)
----------------------------------------------------------------------------------------------------
1a. Identity of the issuer Hikma Pharmaceuticals plc
or the underlying issuer
of existing shares to which
voting rights are attached(ii)
:
------------------------------------------- -------------------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer
(please mark with an "X" if appropriate)
----------------------------------------------------------------------------------------------------
Non-UK issuer
------------------------------------------------------------------------------------- -------------
2. Reason for the notification (please mark the appropriate
box or boxes with an "X")
----------------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
------------------------------------------------------------------------------------- -------------
An acquisition or disposal of financial instruments
------------------------------------------------------------------------------------- -------------
An event changing the breakdown of voting rights
------------------------------------------------------------------------------------- -------------
Other (please specify)(iii) :
------------------------------------------------------------------------------------- -------------
3. Details of person subject to the notification obligation(iv)
Name The Capital Group Companies,
Inc. ("CGC")
City and country of registered Los Angeles, CA 90071, USA
office (if applicable)
4. Full name of shareholder(s) (if different from 3.)(v)
----------------------------------------------------------------------------------------------------
Name
------------------------------------------- -------------------------------------------------------
City and country of registered
office (if applicable)
------------------------------------------- -------------------------------------------------------
5. Date on which the threshold 05/04/2018
was crossed or reached(vi) (see also box 11 Additional
: information)
------------------------------------------- -------------------------------------------------------
6. Date on which issuer notified 25/04/2018
(DD/MM/YYYY):
------------------------------------------- -------------------------------------------------------
7. Total positions of person(s) subject to the notification
obligation
----------------------------------------------------------------------------------------------------
% of voting % of voting Total of Total number
rights attached rights through both in % of voting
to shares financial (8.A + 8.B) rights of
(total of instruments issuer(vii)
8. A) (total of
8.B 1 + 8.B
2)
------------------ ----------------------- ---------------- ---------------------- -------------
Resulting
situation
on the date
on which
threshold
was crossed
or reached 11.007% 0.000% 11.007% 240,866,696
------------------ ----------------------- ---------------- ---------------------- -------------
Position 10.7829% 0.000% 10.7829%
of previous (see also (see also
notification box 11 Additional box 11 Additional
(if information) information)
applicable)
------------------ ----------------------- ---------------- ---------------------- -------------
8. Notified details of the resulting situation on the
date on which the threshold was crossed or reached(viii)
--------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares
--------------------------------------------------------------------------------------------------------------
Class/type Number of voting rights(ix) % of voting rights
of
shares
ISIN code
(if possible)
----------------------
Direct Indirect Direct Indirect
(Art 9 of (Art 10 of (Art 9 of (Art 10 of
Directive Directive Directive Directive
2004/109/EC) 2004/109/EC) 2004/109/EC) 2004/109/EC)
(DTR5.1) (DTR5.2.1) (DTR5.1) (DTR5.2.1)
--------------------- --------------------- -------------- ------------------------------ ---------------
Ordinary
GB00B0LCW083 26,511,744 11.007%
---------------------- --------------------- -------------- ------------------------------ ---------------
SUBTOTAL
8. A 26,511,744 11.007%
---------------------- ------------------------------------- -----------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a)
of Directive 2004/109/EC (DTR5.3.1.1 (a))
--------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date(x) Conversion rights that rights
Period(xi) may be acquired
if the instrument
is
exercised/converted.
---------------------- --------------------- -------------- ------------------------------ ---------------
SUBTOTAL 8.
B 1
-------------- ------------------------------ ---------------
B 2: Financial Instruments with similar economic effect
according to Art. 13(1)(b) of Directive 2004/109/EC
(DTR5.3.1.1 (b))
--------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Physical Number % of voting
financial date(x) Conversion or cash of voting rights
instrument Period settlement(xii) rights
(xi)
--------------------- ---------------------- -------------- ----------------- ----------- ---------------
SUBTOTAL
8.B.2
----------------- ----------- ---------------
9. Information in relation to the person subject to
the notification obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is
not controlled by any natural person or legal entity
and does not control any other undertaking(s) holding
directly or indirectly an interest in the (underlying)
issuer(xiii)
Full chain of controlled undertakings through which X
the voting rights and/or the
financial instruments are effectively held starting
with the ultimate controlling natural person or
legal entity(xiv) (please add additional rows as
necessary)
------------------------------------------------------------------------ ---------------------
Name(xv) % of voting % of voting Total of both
rights if it rights through if it equals
equals or is financial instruments or is higher
higher than if it equals than the notifiable
the notifiable or is higher threshold
threshold than the notifiable
threshold
------------------------- ------------------ ------------------------- ---------------------
The Capital
Group Companies,
Inc.
Holdings by
CG Management
companies are
set out below: 11.007% 0.000% 11.007%
------------------------- ------------------ ------------------------- ---------------------
-- Capital Research
and Management
Company(1) 11.007% 0.000% 11.007%
------------------------- ------------------ ------------------------- ---------------------
EuroPacific
Growth Fund
("EUPAC")(2) 6.581% 0.000% 6.581%
------------------------- ------------------ ------------------------- ---------------------
(1) Subsidiary of The Capital Group Companies, Inc.
(2) Mutual fund managed by Capital Research and Management
Company.
-----------------------------------------------------------------------------------------------
10. In case of proxy voting, please identify:
-----------------------------------------------------------------------------------------------
Name of the proxy holder
--------------------------------------------- ------------------------------------------------
The number and % of voting
rights held
--------------------------------------------- ------------------------------------------------
The date until which the
voting rights will be held
--------------------------------------------- ------------------------------------------------
11. Additional information(xvi)
-----------------------------------------------------------------------------------------------
Please note that since 07/12/2017 the following thresholds
have been crossed by CGC, all relating to indirect
holdings of voting rights attaching to shares:
* On 07/12/2017 CGC crossed above a threshold of 10%
with a resulting holding of 25,950,451 shares
representing 10.7829% of total voting rights. A TR-1
notification was submitted on behalf of CGC on 11
December 2017.
* On 08/12/2017 CGC crossed above a threshold of 11%
with a resulting holding of 27,251,953 shares
representing 11.324% of total voting rights. No TR-1
notification was submitted on behalf of CGC at that
time.
* On 11/12/2017 CGC crossed above a threshold of 12%
with a resulting holding of 29,110,072 shares
representing 12.096% of total voting rights. No TR-1
notification was submitted on behalf of CGC at that
time.
* On 05/03/2018 CGC crossed below a threshold of 12%
with a resulting holding of 28,691,617 shares
representing 11.921% of total voting rights. No TR-1
notification was submitted on behalf of CGC at that
time.
* On 14/03/2018 CGC crossed below a threshold of 11%
with a resulting holding of 25,903,432 shares
representing 10.763% of total voting rights. No TR-1
notification was submitted on behalf of CGC at that
time.
* On 05/04/2018 CGC crossed above a threshold of 11%
with a resulting holding of 26,511,744 shares
representing 11.007% of total voting rights. The
present TR-1 notification is being submitted on
behalf of CGC in relation to this crossing.
CGC is the parent company of Capital Research and Management
Company ("CRMC"). CRMC is a U.S.-based investment management
company that manages the American Funds family of mutual
funds. CRMC manages equity assets for various investment
companies through three divisions, Capital Research
Global Investors, Capital International Investors and
Capital World Investors. CRMC in turn is the parent
company of Capital Group International, Inc. ("CGII"),
which in turn is the parent company of five investment
management companies ("CGII management companies"):
Capital Guardian Trust Company, Capital International,
Inc., Capital International Limited, Capital International
Sàrl and Capital International K.K. The CGII management
companies primarily serve as investment managers to
institutional clients.
Neither CGC nor any of its affiliates own shares of
Hikma Pharmaceuticals plc for its own account. Rather,
the shares reported on this Notification are owned
by accounts under the discretionary investment management
of one or more of the investment management companies
described above.
-----------------------------------------------------------------------------------------------
Place of completion Los Angeles, CA, USA
------------------------ -----------------------------------------------------------------------
Date of completion 25/04/2018
------------------------ -----------------------------------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUNOURWNASUAR
(END) Dow Jones Newswires
April 26, 2018 08:40 ET (12:40 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024
